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Asf1 is a histone chaperone that favors histone
H3/H4 assembly and disassembly. We solved
the structure of the conserved domain of human
ASF1A in complex with the C-terminal helix of
histone H3 using nuclear magnetic resonance
spectroscopy. This structure is fully compatible
with an association of ASF1 with the hetero-
dimeric form of histones H3/H4. In our model,
ASF1 substitutes for the second H3/H4 hetero-
dimer that is normally found in heterotetrameric
H3/H4 complexes. This result constitutes an es-
sential step in the fundamental understanding of
the mechanisms of nucleosome assembly by
histone chaperones. Point mutations that per-
turb the Asf1/histone interface were designed
from the structure. The decreased binding affin-
ity of the Asf1-H3/H4 complex correlates with
decreased levels of H3-K56 acetylation and
phenotypic defects in vivo.
INTRODUCTION
Histone chaperones are proteins that facilitate the assem-
bly of histones with DNA to form the nucleosome, and they
are also implicated in the reverse disassembly of nucleo-
somes. This terminology was chosen by analogy with
other protein chaperones that associate with a protein tar-
get to prevent its misfolding or aggregation and favor its
proper folding or association with other macromolecules,
and then dissociate from the protein or the complex. His-
tone chaperones show a preferential affinity for either his-
tones H2A/H2B or H3/H4. They are functionally special-
ized in histone storage, histone targeting to the nucleus,
histone buffering in the nucleus, and histone assembly/
disassembly in DNA replication-coupled or DNA replica-
tion-independent processes (Loyola and Almouzni, 2004).Structure 15, 191–1Asf1 (antisilencing function 1) is a highly conserved his-
tone chaperone found in the nucleus associated with his-
tones H3/H4 (Tyler et al., 1999; Munakata et al., 2000). It
has a conserved N-terminal domain of 156 amino acids
and a divergent C-terminal sequence that does not appear
to be structured and that is dispensable for most Asf1
functions in vivo (Daganzo et al., 2003; Umehara et al.,
2002; Mousson et al., 2005). It is implicated in nucleosome
assembly and disassembly associated with a large num-
ber of physiological pathways including gene silencing
(Le et al., 1997; Sharp et al., 2001), DNA replication (Mello
et al., 2002; Tyler et al., 1999), gene transcription (Adkins
et al., 2004; Schwabish and Struhl, 2006), and DNA dam-
age signaling and repair (Emili et al., 2001; Hu et al., 2001).
It has also been proposed that Asf1 could prevent the
toxic effects associated with the accumulation of free his-
tones in cells after DNA replication blocks (Groth et al.,
2005). In yeast, Asf1 is required for the acetylation of his-
tone H3-K56, and this histone modification is necessary
for resistance to genotoxic stress (Recht et al., 2006;
Masumoto et al., 2005). Consistent with its multiple func-
tions, Asf1 associates with more than seven partners, and
these transient interactions could participate in the specific
recruitment of Asf1 to different pathways.
Although the functional implication of histone chaper-
ones in numerous physiological pathways is now well es-
tablished, little structural information is available concern-
ing their binding mode. The high-resolution structures of
only three histone chaperones have been solved, includ-
ing that of human and yeast Asf1 (Daganzo et al., 2003;
Dutta et al., 2001; Mousson et al., 2005; Park and Luger,
2006; Padmanabhan et al., 2005), but no high-resolution
structure of a histone chaperone interacting with histones
is available. In a previous study, using nuclear magnetic
resonance (NMR) spectroscopy, we mapped the chemi-
cal-shift variations of human ASF1A upon binding of the
C-terminal helix of histone H3 and found that the binding
surface is composed of a highly conserved hydrophobic
groove surrounded by charged residues (Mousson et al.,
2005). Mutations of the central exposed hydrophobic
residue V94R completely destabilized the Asf1-H3/H499, February 2007 ª2007 Elsevier Ltd All rights reserved 191
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Structure of Asf1 with Histones H3/H4Figure 1. Structure of Asf1a (1–156) in
Complex with Histone H3 (122–135)
(A) Stereo view of the superposition of the ten
best structures calculated as indicated in the
text. Asf1 is colored in gray and the histone
peptide is in magenta. N and C termini and
the corresponding residue number in the full
protein are indicated for both chains.
(B) Stereo view of the superposition of the side
chain heavy atoms of hydrophobic residues
involved in the interfacial hydrophobic patch.
The orientation of the molecule is the same
as in (A). Residues of ASF1A are shown in
gray and histone H3 is in magenta. Residue
numbers of highlighted residues are indicated.interaction. In vivo, this mutation led to transcriptional si-
lencing defects in yeast, DNA damage sensitivity, and
thermosensitive growth, suggesting that histone binding
is required for all major functions of Asf1.
An important question remaining is how histone chaper-
ones assemble histones with DNA. In order to provide a
more detailed description of the histone binding mode of
Asf1, we solved the structure of the complex of the con-
served N-terminal Asf1 histone-binding domain with the
histone H3 C-terminal peptide using NMR spectroscopy.
This structure allowed us to infer a model for the complex
between Asf1 and the entire H3/H4 complex. We found
that Asf1 likely interacts with the heterodimeric form of
the complex, whereas the structure is not compatible
with an association with the tetrameric form of histone
H3/H4. Rather, Asf1 substitutes for the second H3/H4
dimer and forms a highly specific interface that combines
a nicely packed hydrophobic core and an intricate salt-
bridge network.192 Structure 15, 191–199, February 2007 ª2007 Elsevier LtdRESULTS
We determined the structure of the conserved core of
human ASF1A (amino acids 1–156) in complex with the
C-terminal helix of histone H3 (amino acids 122–135) us-
ing multidimensional NMR spectroscopy (Figure 1A; Table
1). Complete assignment of resonances of the histone-
bound form and the collection of intramolecular nuclear
Overhauser effects (NOEs) and 116 filtered NOE contacts
provided enough distances to build a high-resolution
structure of the complex with a root-mean-square devia-
tion (rmsd) of 0.74 A˚ for all backbone atoms of the com-
plex (Figure 1A; Table 1). The two last residues of histone
H3 are less defined than the helix (2.06 A˚ backbone rmsd).
This is compatible with the increased dynamic of the C-
terminal tail as measured by the heteronuclear 15N{1H}-
NOEs (see Figure S1 in the Supplemental Data available
with this article online). The helical histone peptide docks
against the highly conserved hydrophobic exposedAll rights reserved
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Structure of Asf1 with Histones H3/H4surface of human ASF1A that was previously highlighted
by our chemical-shift perturbation analysis (Mousson
et al., 2005). The binding interface represents 430 A˚2
and is quite shallow. It is composed of a well-defined hy-
Table 1. Structural Statistics for the Structure of the
Human ASF1A (1–156)/H3 (122–135) Complex
List of Restraints
Number of experimental restraints
Distance restraints from NOEs
Intramolecular ASF1A 4489
Intramolecular H3 340
Intermolecular 116
Hydrogen bonds 70
Dihedral angle constraints 170
Structural analysisa
Average number of NOE violations
greater than 0.5 A˚ (%)
0.01
Average number of hydrogen
bond violations
0
Average number of dihedral
violations greater than 5 (%)
0.003
Rmsd from experimental restraintsa
NOE distances (A˚) 0.022 ± 0.005
Hydrogen bonds 0.05 ± 0.003
Dihedral angles () 0.92 ± 0.15
Rmsd from ideal geometrya,b
Bond (A˚) 0.0061 (± 0.0002)
Angle () 0.71 (± 0.02)
Impropers () 0.70 (± 0.04)
Rmsd from average structurea
Backbone, second structure (A˚) 0.41 (± 0.06)
Heavy atoms, second structure (A˚) 0.74 (± 0.07)
Backbone, all residues (A˚) 0.73 (± 0.09)
Heavy atoms, all residues (A˚) 1.07 (± 0.09)
Procheck analysisc
Residues in most favored
region (2388)
80.1%
Residues in additionally allowed
region (557)
18.7%
Residues in generously allowed
region (23)
0.8%
Residues in most disfavored
region (12)
0.4%
a For the 30 calculated structures.
b Idealized geometries based on CNS parameters
(PARALLHDG) (Brunger et al., 1998).
c For the 20 deposited structures. The number of residues in
the ensemble of 20 structures is indicated in parentheses.Structure 15, 191–1drophobic clamp surrounded by an extensive network of
salt bridges (Figures 1B and 2A). The hydrophobic clamp
involves the side chain of two histone H3 residues, L126
and I130, that nicely pack against the exposed hydropho-
bic residues of ASF1 V45, V92, V94, L96, and Y112 (Fig-
ure 1B). These residues are highly conserved in the Asf1
and H3 sequences (Figure S2). The hydrophobic moiety
of histone H3-K122 packs against the methyl group of
A48 and V92 of ASF1A, whereas its guanidinium group
forms a partly buried salt bridge with ASF1A D88. This
negatively charged residue is conserved in all sequences
of Asf1 and is found buried in the two known structures
of the free proteins (human and yeast) (Daganzo et al.,
2003; Mousson et al., 2005), although it is not involved in
a salt bridge in these forms. The highly conserved residues
of ASF1 (D54, E105, R108) and the H3 peptide (R129,
R134, along with the C-terminal helix dipole and the C
terminus) define an intricate network of salt bridges and
hydrogen bonds that stabilize the complex (Figure 2A),
with D54/R129, E105/R134, and the R108/H3 helix dipole
formed in almost all calculated structures. In summary,
histone H3 (122–135) interacts with Asf1 through a well-
defined binding interface that combines hydrophobic
and electrostatic interactions. All the side chains involved
in the interaction are among the most highly conserved
residues exposed at the surface of Asf1, in agreement
with a conserved ability of Asf1 to bind histones.
The structure of ASF1A is almost unchanged (rmsd of
1.38 A˚ for backbone atoms) after binding the histone H3
fragment (122–131), and theH3 fragment folds intoahelical
conformation that is nearly superimposable with helix a3
observed in the intact H3/H4 complex (Mousson et al.,
2005). Based on this result, we derived a model for Asf1 as-
sociated with the complete histone H3/H4 complex (Fig-
ure 2B) by simply superimposing the region (122–131) of
histone H3 complexed to ASF1A with the corresponding
helix a3 of the H3/H4 complex (Harp et al., 2000). Remark-
ably, no steric clash between backbone atoms is found
between ASF1A and the dimeric form of histones H3/H4,
and a simple energy minimization of the modeled structure
released all clashes between side chains. In contrast, the
histone H3 binding interface with ASF1A is not compatible
with an association with the tetrameric form of histones
H3/H4. Our structural data thus strongly suggest that
Asf1 interacts preferentially with the dimeric form of the
H3/H4 complex and are consistent with the stoichiometry
found for the complex purified from recombinant coex-
pressed Asf1/H3/H4 (English et al., 2005).
In the structural model of ASF1A in complex with the
heterodimeric form of histones H3/H4, the region corre-
sponding to the H3 peptide fragment (122–135) covers
85% of the total surface of interaction buried in the model
by the entire histone complex. The remaining 15% of the
surface mainly involves H113, C110, and D106 in the a2
of histone H3. These residues contact Y112, L140, and
R145 of ASF1A, which are highly conserved residues at
the surface of Asf1 (Figure S2). Remarkably, there is a
strong overlap between the surface of H3 that becomes
buried upon Asf1 binding and upon binding to a second99, February 2007 ª2007 Elsevier Ltd All rights reserved 193
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Structure of Asf1 with Histones H3/H4Figure 2. Asf1 Associates with the Het-
erodimeric Form of the H3/H4 Complex
and Takes the Place Normally Occupied
by the Second H3/H4 Dimer in Heterote-
trameric H3/H4
In all four panels, the orientation of helix a3 is
identical to that of Figure 1.
(A) Close-up view of the complex interface
between ASF1A (1–156) and histone H3 (122–
135). The side chains of the hydrophobic resi-
dues involved in the hydrophobic clamp are
represented as spheres and colored by ele-
ment, with a gray color for carbons of ASF1A
residues and a magenta color for carbons of
histone H3. The side chains of the charged res-
idues involved in the network of salt bridges
and hydrogen bonds are represented as sticks
and colored by element, with a gray color for
carbons of ASF1A residues and a magenta
color for carbons of histone H3. Residue num-
bers of highlighted residues and the C terminus
of histone H3 are indicated by the same color
code.
(B) Cartoon representation of the structural
model of ASF1A (1–156) in complex with the
histone H3/H4 dimer. The region (amino acids
122–135) of histone H3 in the H3/H4 complex
(Protein Data Bank [PDB] ID code 1EQZ)
(Harp et al., 2000) was superimposed on resi-
dues 122–135 of the histone H3 peptide bound
to ASF1A. ASF1A is colored in gray, the resi-
dues 122–135 of histone H3 are colored in ma-
genta, and the other residues of histone H3 are
colored in gray-rose. Histone H4 is colored in
light blue. The position of H3-K56 is indicated.
(C) Close-up view of the interface between H3 and H30 in the heterotetramer (PDB ID code 1EQZ) (Harp et al., 2000), with the color code magenta for
histone H3 (122–135), gray-rose for other residues of histone H3, dark gray for histone H30, and light gray for histone H40. Residue numbers of high-
lighted residues are indicated by the same color code. The side chains of the residues of histone H3 (122–135) involved in the interaction with ASF1A
(1–156) are represented as spheres for hydrophobic residues and sticks for charged residues as in (A). They are also colored by element, with a
magenta color for carbons. Residues of histone H30 in contact are shown with a gray color for carbons, with spheres for hydrophobic residues
and sticks for charged residues.
(D) Cartoon representation of the heterotetrameric complex of histone H3/H4 (PDB ID code 1EQZ) (Harp et al., 2000). The color code is magenta for
histone H3 (122–135), gray-rose for the other residues of histone H3, light blue for histone H4, dark gray for histone H30, and light gray for histone H40.H3/H4 subunit to form the heterotetrameric H3/H4 com-
plex (Figure 2). In particular, the two histone H3 residues
L126 and I130 that participate in the hydrophobic clamp
with Asf1 (Figure 2A) also stabilize the four-helix bundle
found at the interface between the two H3 molecules in
the histone H3/H4 heterotetramer (Figure 2C) (Harp
et al., 2000; Luger et al., 1997; White et al., 2001). In sum-
mary, the structure of Asf1 with the histone H3 (122–135)
fragment is consistent with an association of Asf1 with
the heterodimeric form of the H3/H4 complex, but not
with the tetrameric form because Asf1 takes the place
that would normally be occupied by the second H3/H4
dimer.
In a previous study, we showed that the V94R mutation
of ASF1A disrupts its ability to bind the histone H3/H4
complex, whereas the D54R and R108E mutations only
destabilize the complex (Mousson et al., 2005). The
high-resolution structure of ASF1A in complex with his-
tones H3/H4 now provides a structural basis for under-
standing the effect of such mutations. Residue V94 of194 Structure 15, 191–199, February 2007 ª2007 Elsevier Ltd AAsf1 is located at the center of the hydrophobic clamp
and is in close contact with L126 and I130 of histone H3.
Its mutation into a bulky positively charged arginine resi-
due (V94R) generates steric clashes and electrostatic
repulsions so that the complex is strongly destabilized.
Residues D54 and R108 of ASF1A are located at the
edge of the binding surface and are involved in the net-
work of salt bridges with histone H3. D54 makes a salt
bridge with R129, and R108 caps the C terminus of helix
a3. The mutation of D54 and R108 into oppositely charged
residues perturbs the formation of the salt bridges, but the
corresponding side chains may adopt alternative confor-
mations to prevent steric clashes leading to only minor
complex destabilization. Nevertheless, the D54R+R108E
double mutant has greater phenotypic defects, consistent
with an important stabilizing role for these salt bridges.
We used the high-resolution structural model of Asf1 in
complex with histones H3/H4 for the rational design of H3
point mutations likely to perturb its interaction with Asf1
without perturbing the structure of the dimeric andll rights reserved
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Structure of Asf1 with Histones H3/H4tetrameric forms of the histone H3/H4 complex and the
nucleosome particle (Figures 2A and 2C). We then tested
the phenotype of such mutants as the sole histone H3
source in Saccharomyces cerevisiae. Residues D106,
C110, H113, L126, and I130 of H3 hydrophobically inter-
act with Asf1, but cannot be mutated without perturbing
the H3/H4 heterotetrameric interface (Figure 2C). Residue
K122 points toward the DNA, and its mutation is expected
to perturb the interaction with DNA (Figure 2C). Indeed,
the H3-K122E mutant is inviable (data not shown). In con-
trast, R129 and R134 are involved in salt bridges with Asf1,
but are not involved in salt bridges in any of the available
nucleosome structures (Harp et al., 2000; Luger et al.,
1997; White et al., 2001). Accordingly, the mutation of
these residues should not affect the structure of the H3/H4
dimer, the H3/H4 tetramer, or the nucleosome. The H3-
R134E mutant is viable and has no detectable phenotype
(data not shown), indicating that the Asf1-H3/H4 binding
surface can accommodate this particular mutation. This
result is consistent with the elevated mobility observed
for this residue in the NMR structure.
Interestingly, the H3-R129E mutant is viable, but, like
the asf1D mutant, it has a slow-growth phenotype and
is hypersensitive to hydroxyurea (HU), an inhibitor of ribo-
nucleotide reductase that induces replicative stress by re-
ducing dNTP pools (Figure 3A). However, unlike the asf1D
mutant, the H3-R129E mutant is relatively resistant to
treatment with camptothecin (CPT), an inhibitor of DNA
topoisomerase I, and to the methylating agent methyl
methane sulfonate (MMS). Asf1 was previously shown to
be required for the acetylation of H3-K56, and this acety-
lation is important in the resistance of yeast to genotoxic
stress (Recht et al., 2006; Masumoto et al., 2005). Some
mutations within the H3 binding surface of Asf1 were
shown to have lower levels of H3-K56 acetylation, but
the H3 binding affinity of these mutants was not deter-
mined (Recht et al., 2006). We thus extended this charac-
terization to our Asf1 mutants whose affinity for binding
the H3/H4 complex had been determined (Mousson
et al., 2005). An excellent correlation is seen for these
mutants in the degree to which they were defective in
binding the H3/H4 complex in vitro, and the defect in the
acetylation of H3-K56 in the corresponding mutant yeast
cells. The Asf1-V94R mutant is totally defective in binding
H3/H4 in vitro, and we observed a loss of H3-K56 acetyla-
tion in the asf1-V94R mutant cells that is similar to that
observed in an asf1D mutant (Figure 3B). In contrast, the
Asf1-D54R and Asf1-R108E mutants were only partially
defective in binding H3/H4 in vitro, and the corresponding
mutant cells are only partially defective in H3-K56 acetyla-
tion. Finally, the asf1-D54R+R108E double mutant has
phenotypic defects that are greater than either single
mutant, but less than the asf1-V94R mutant, and, accord-
ingly, asf1-D54R+R108E mutant cells have residual
H3-K56 acetylation that is intermediate between the
asf1-V94R and asf1-D54R or asf1-R108E mutant cells.
The level of H3-K56 acetylation thus appears to be a
remarkable in vivo metric for the affinity of Asf1 for the
histone H3/H4 complex.Structure 15, 191–1We next characterized the level of H3-K56 acetylation
associated with the H3-R129E and H3-R134E mutants.
The H3-R134E mutant has a level of H3-K56 acetylation
that is similar to the wild-type, which is consistent with
its absence of phenotypic defects (data not shown). In
contrast, the H3-R129E mutant has lower H3-K56 acetyla-
tion than the wild-type (Figure 3B). This result strongly
suggests that the H3-R129E mutation reduces the affinity
of the mutant for Asf1, but does not abolish the interaction.
The decreased affinity of the H3-R129E mutant for Asf1
was confirmed by coimmunoprecipitation experiments.
H3-R129E and H4 were not found associated with Asf1-
myc immunoprecipitated from yeast extracts under con-
ditions in which the wild-type H3 and H4 were readily
observed (Figure 3C). The absence of H3-R129E in the
Asf1-myc immunoprecipitates indicates that it is a more
stringent assay for Asf1-H3/H4 interaction, and thus less
sensitive to the detection of partially functional mutants
compared to the H3-K56 acetylation assay. The de-
creased H3-K56 acetylation of H3-R129E may contribute
to the slow growth and HU sensitivity of the H3-R129E
mutant yeast cells. Indeed, the H3-K56Q mutant mimics
a K56-acetylated H3, and expression of this mutant in
place of the wild-type H3 was shown to partially suppress
the growth and HU sensitivity of an asf1D mutant (Recht
et al., 2006). The relative resistance of the H3-R129E cells
to CPT and MMS may be due to the residual H3-K56 acet-
ylation of this mutant. A nonacetylatable H3-K56R mutant
is sensitive to HU, CPT, and MMS (Masumoto et al., 2005),
but suppression of the CPT and MMS sensitivity of the
asf1D mutant by H3-K56Q has not been reported. We
transformed an asf1D mutant with a centromeric plasmid
expressing the H3-K56Q mutant from the endogenous
HHT2 promoter. Remarkably, the expression of one copy
of H3-K56Q in the asf1D mutant significantly suppresses
its sensitivity to CPT and MMS in addition to its HU sensi-
tivity (Figure 3D). No effect was seen upon expression of
an extra copy of wild-type H3 or an H3-K56R mutant
that mimics a nonacetylated form of histone H3. Taken to-
gether, these results suggest that the residual H3-K56
acetylation of the H3-R129E mutant is sufficient to provide
resistance to CPT and MMS. The HU sensitivity of H3-
R129E may reflect the need for a greater level of H3-K56
acetylation in the cellular response to HU, or the need
for a high-affinity interaction of Asf1 with H3 for reasons
other than K56 acetylation. It is also possible that the
R129E mutation affects the interaction of H3 with an addi-
tional partner.
DISCUSSION
Several studies have shown that a heterotetramer of his-
tones H3/H4 is the most stable form of the complex at
physiological buffer conditions. Furthermore, hybrid den-
sity experiments in mammalian tissue culture cells have
indicated that nucleosomal tetrameric H3/H4 is rarely
dissociated into H3/H4 heterodimers (Annunziato, 2005).
It was thus surprising that histone H3/H4 predeposition
complexes purified from HeLa cells were shown to contain99, February 2007 ª2007 Elsevier Ltd All rights reserved 195
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Structure of Asf1 with Histones H3/H4Figure 3. Phenotype of the Histone H3-R129E Mutant, H3-K56 Acetylation in asf1 and H3 Mutant Cells, Lack of Coimmunopreci-
pitation of H3-R129E and Asf1-Myc, and Suppression of the Sensitivity of the asf1DMutant to Genotoxic Stress by Expression of
H3-K56Q
(A) The H3-R129E (hht2-R129E) mutant yeast strain is sensitive to 100 mM hydroxyurea (HU), but not to 14 mM camptothecin (CPT) or 0.01% methyl
methane sulfonate (MMS). Yeast strains grown to early stationary phase in a yeast extract-peptone-dextrose (YPD) broth were spotted in 10-fold
dilutions on the indicated media and incubated for 4 days at 30C.
(B) The level of H3-K56 acetylation in whole-cell protein extracts prepared from the indicated wild-type and mutant yeast strains was determined by
immunoblotting with anti-H3-K56-acetyl antibodies (Upstate Biotechnology). The level of total histone H3 protein in the same extracts was assayed
with an antibody directed against H3 residues 100–135 (Abcam, 1791). The left panel compares the wild-type and the indicated asf1 mutants,
whereas the right panel compares the wild-type, the asf1D mutant, and the H3-R129E (hht2-R129E) mutant.
(C) Asf1-myc was immunoprecipitated from 1 mg of protein extract from yeast strains expressing only wild-type Hht2 or the Hht2-R129E mutant.
Immunoprecipitated proteins were then analyzed by SDS-PAGE and immunoblotting with anti-myc and anti-H3 and anti-H4 antibodies as described
in Experimental Procedures. Forty micrograms of S100 protein extract was also analyzed to evaluate the efficiency of Asf1-myc immunoprecipitation.
A strain that does not express Asf1-myc was used as a specificity control for the anti-myc immunoprecipitation.
(D) Suppression of the sensitivity of the asf1D mutant to genotoxic stress by expression of an extra copy of H3-K56Q, but not wild-type H3 or
H3-K56R. A W303 asf1D::kanMX mutant strain was transformed with centromeric plasmid pRS414 (vector), or with the same plasmid expressing
genes for wild-type H3/H4 (HHT2-HHF2; indicated as pH3-WT), expressing the H3-K56R mutant with wild-type H4 (hht2-K56R-HHF2; indicated
as pH3-K56R), or expressing the H3-K56Q mutant with wild-type H4 (hht2-K56Q-HHF2; indicated as pH3-K56R). Transformed cells were then grown
to early stationary phase in a synthetic medium without tryptophan to maintain selection for the pRS414 plasmids, and cells were then spotted in
10-fold dilutions on the indicated media and incubated for 4 days at 30C. A wild-type strain containing the pRS414 vector was also spotted
as a control for the wild-type level of resistance to these genotoxic agents. Expression of one extra copy of HHT2-HHF2, hht2-K56R-HHF2, or
hht2-K56Q-HHF2 in the wild-type strain did not affect its resistance to these genotoxic agents (data not shown).196 Structure 15, 191–199, February 2007 ª2007 Elsevier Ltd All rights reserved
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Structure of Asf1 with Histones H3/H4heterodimeric forms of H3/H4 (Tagami et al., 2004). Coex-
pression of the N-terminal domain of yeast Asf1 with
histones H3/H4 also led to the formation of 1/1/1 heterotri-
meric complexes of Asf1 with an H3/H4 heterodimer
(English et al., 2005). Our current structural data of the hu-
man ASF1A N-terminal domain bound to the C-terminal
helix peptide of histone H3 provide the structural basis
for these observations. Asf1 occupies the same surface
of this peptide that would normally be bound by the sec-
ond H3/H3 heterodimer found in the tetrameric H3/H4
complexes. Because H3/H4 heterotetramers are in dy-
namic equilibrium with the heterodimers, the presence of
Asf1 would displace the second heterodimer from the
complex if its affinity for the H3/H4 heterodimer is higher
than that of H4/H4 itself. The presence of Asf1-H3/H4 pre-
deposition complexes must still be reconciled with the
data indicating that nucleosomal H3/H4 heterotetramers
rarely dissociate in cells (Annunziato, 2005). A concerted
deposition of newly synthesized H3/H4 heterodimers
would be consistent with all current data and might ex-
plain the complexity of the predeposition complexes that
contain several distinct histone chaperones.
Asf1 is required for histone H3-K56 acetylation in yeast,
and a correlation was observed, with one exception, for
asf1 mutant cells that lack H3-K56 acetylation and sensi-
tivity to genotoxic stress (Recht et al., 2006). Mutants
with reduced H3-K56 acetylation were localized to the
H3 binding surface that we had previously defined by
NMR chemical-shift perturbation analysis. We have now
extended this analysis to mutants of Asf1 that we had pre-
viously characterized in terms of their binding affinity to the
H3/H4 complex in vitro and their phenotypic defects in
yeast cells. An excellent correlation is found between their
histone-binding defect in vitro, the degree of residual H3-
K56 acetylation in vivo, and the phenotypic defects of the
mutants. These results support the conclusion that the
Asf1-H3/H4 interaction is required for H3-K56 acetylation
that is in turn required for the resistance to genotoxic stress
(Hyland et al., 2005; Masumoto et al., 2005; Recht et al.,
2006). The precise role of H3-K56 acetylation in these pro-
cesses remains to be determined. Our current structural
data allow us to further propose that the association of
Asf1 with the heterodimeric form of histone H3/H4 is re-
quired for an efficient acetylation of K56 in yeast. These
data show that residue K56 is located at the opposite
side of histone H3 from Asf1 (Figure 2B). It is thus unlikely
that Asf1 shields acetylated K56 from deacetylases, which
is consistent with work showing that H3-K56 acetylation is
still absent in asf1mutants that lack the Hst3 and Hst4 H3-
K56 deacetylases (Celic et al., 2006). We propose instead
that Asf1 is required to recruit one or more H3-K56 acetyl
transferases to the Asf1-H3/H4 heterodimeric complex.
During the review of this paper, Tyler and coworkers
published the structure of the conserved domain of yeast
Asf1 (1–169) cocrystallized with Xenopus histones H3
(60–135)/H4 (20–101) (English et al., 2006). In this struc-
ture, the orientation of the H3 C-terminal helix is identical
to that observed in our structure with the histone fragment
only (with an rmsd of 2.19 A˚ for backbone atoms of Asf1Structure 15, 191[1–156] and histone H3 [122–134]). In both structures,
the hydrophobic clamp involves residues L126 and I130
of histone H3 and V45, V92, V94, L96, and Y112 of Asf1,
and the network of salt bridges includes the salt bridge be-
tween Asf1-D54 and histone H3-R129 which was targeted
by our mutagenesis. The high B factor for R134 and the
absence of electron density for the last residue A135 in
the crystal structure of the complex are also consistent
with the mobility of the last two residues observed in the
NMR structure and dynamics, and the absence of pheno-
type of the R134E mutant. The two structures differ slightly
in the region around histone H3-K122. In the crystal struc-
ture, the charged extremity of the side chain of K122
points toward the polar side chains of S91 and S48,
whereas in our NMR structure, the hydrophobic moiety
of histone H3-K122 packs against the methyl group of
A48 and V92 of ASF1A and its guanidinium group forms
a partly buried salt bridge with ASF1A-D88. These differ-
ences may result from sequence variation between yeast
Asf1 and human ASF1A in which S48 is replaced by A48
and S91 by G91. The structure we observe likely repre-
sents an alternative arrangement of the Asf1/histone H3
interface in this region. This arrangement is probably the
most common, as the majority of Asf1 sequences show
an alanine residue in position 48 and a glycine in position
91 as in the human ASF1A sequence (Figure S2).
The comparison of our model derived from the structure
with the peptide with the crystal structure validates the
modeling for the global orientation of the two molecules
with each other (rmsd of 3.84 A˚ for backbone atoms of
Asf1 [1–156], histone H3 [60–134], and histone H4 [31–
93]), and in particular for the association of Asf1 with the
dimeric H3/H4 complex. The interactions with the helix
a2 were also well predicted in our model. However, the
crystal structure with the histone H3/H4 complex also re-
veals additional interactions with the C-terminal part of
histone H4. For this interaction, the C-terminal residues
of histone H4 undergo a large conformational change
and form a b strand paired with strand b9 of Asf1. We could
not have predicted this interaction by our approach. This
additional interaction likely reinforces the Asf1/histone in-
teraction and is consistent with a higher affinity of Asf1 for
the full histone H3/H4 complex compared to the modest
affinity for the histone C-terminal helix. In conclusion, we
determined the NMR solution structure of the N-terminal
domain of human Asf1a with the C-terminal helix of his-
tone H3, which provided the structural basis for Asf1 asso-
ciation with the dimeric rather than the tetrameric complex
of histones H3/H4. It also allowed us to design mutations
of histone H3 that perturb this interaction for the in vivo
investigation of its role in H3-K56 acetylation and in the
resistance to genotoxic stress.
EXPERIMENTAL PROCEDURES
Expression and Cloning
15N- and 15N/13C-labeled and unlabeled recombinant human ASF1A
(1–156) were produced and purified as described in Mousson et al.
(2004). Unlabeled histone H3 (122–135) peptide was produced by–199, February 2007 ª2007 Elsevier Ltd All rights reserved 197
Structure
Structure of Asf1 with Histones H3/H4chemical synthesis (Asynth, The Netherlands); uniformly 15N- and
15N/13C-labeled histone H3 (122–135) peptides were produced and
purified as described in Mousson et al. (2005).
Structural Determination of the Complex of ASF1A
(1–156) with Histone H3 (122–135)
All NMR samples were prepared in the following buffer: 10 mM Tris D11
(pH 7.4), 0.1% NaN3, 1 mM EDTA, 0.1 mM 2,2-dimethyl-2-silapentane-
5-sulfonate, 10% or 100% D2O. Several samples were used: uniformly
15N- (or 15N/13C-) labeled ASF1A (1–156) in complex with unlabeled
histone H3 (122–135) or uniformly 15N- (or 15N/13C-) labeled histone
H3 (122–135) in complex with unlabeled ASF1A (1–156). For these
samples, the concentrations of the labeled and unlabeled molecules
were 2 mM and 2.5 mM, respectively. Because the affinity constant
of the complex is approximately 50 mM, 92% of the labeled molecules
were bound to the unlabeled partner in the sample (1856 mM bound
and 144 mM unbound). NMR experiments were carried out on Bruker
DRX 600 MHz and 800 MHz spectrometers equipped with cryoprobes.
1H, 15N, and 13C resonance assignments of the complex were ob-
tained as described in Mousson et al. (2004). Intermolecular NOEs
were obtained by filtered edited experiments described in Zwahlen
et al. (1997). NMR spectra were processed using XWINNMR and ana-
lyzed using SPARKY (T.D. Goddard and D.G. Kneller, University of
California, San Francisco). Peak intensities of the 13C-filtered 15N-
and 13C-edited 3D NOESY-HSQC spectra (with a mixing time of
120 ms) were converted to distance restraints using ARIA (ambiguous
restraints for iterative assignment) (Linge et al., 2001, 2003). One hun-
dred thirteen (f,c) restraints were derived using TALOS (Cornilescu
et al., 1999) and 57 f restraints using 3JHNHa coupling constants de-
rived from the 3D HNHA spectrum (Vuister and Bax, 1994) on the basis
of the empirical Karplus relation they were set to, 60 ± 40 for JHN-Ha
lower than 6 Hz and 120 ± 60 for JHN-Ha higher than 8 Hz. Seventy
hydrogen bonds were used for the calculation. They were introduced
in regular secondary structures defined on the basis of the presence
of the complete set of NOEs expected for b sheets or a helices
(Wu¨thrich, 1986) and consistent values of (f,c) predicted from TALOS.
An overview of the constraints is given in Table 1. Structures were cal-
culated using ARIA 2.0 and CNS 1.1 (Habeck et al., 2004; Brunger
et al., 1998), starting from random structures for both Asf1 and H3 pep-
tides and the PARALLHDG force field. Standard protocols and param-
eters were used as proposed in the ARIA program. Eight iterations
were calculated each on 100 structures, keeping 30 structures for
analysis. Finally, the 30 structures with lowest energy were refined
with explicit water and the 20 best structures were submitted to the
Protein Data Bank (ID code 2IIJ). Salt bridges were assigned when
the distance between the charged heavy atoms was below 3.5 A˚ in
more than half of the 20 best structures.
Mutant Construction and Phenotypic Analyses
Construction of the H3-R129E Mutant
The R129E mutation was introduced by site-specific mutagenesis into
the plasmid pDM18 (pRS414-HHT2-HHF2), a generous gift from A.A.
Duina and F. Winston (Duina and Winston, 2004). The resulting plas-
mid, pH3-R129E = pRS414-hht2-R129E, was transformed into yeast
strain FY2161 MATa his3D200 leu2D1 ura3-52 trpD63 lys2-128
(hht1-hhf1)::LEU2 (hht2-hhf2)::HIS3 Ty912D35-lacZ::his4 pDM9
(pRS416-URA3-HHT1-HHF1) selecting for Trp+ cells. The pDM9URA3
plasmid containing wild-type HHT1-HHF1 was then counterselected
by replicating cells onto a medium containing 5-fluoro-orotic acid.
Suppression of asf1D by the H3-K56Q Mutant
pRS414 centromeric plasmids containing wild-type HHT2-HHF2
(pDM18 above), hht2-K56R (pEMH7-hht2-K56R-HHF2), or hht2-K56Q
(pEMH7-hht2-K56Q-HHF2), the latter two plasmids being generous
gifts of E.M. Hyland and J.D. Boeke (Hyland et al., 2005), were trans-
formed into a W303-1a asf1D::kanMX strain selecting Trp+ transform-
ants. Resistance to genotoxic stress was then assessed by growth on
yeast extract-peptone-dextrose plates containing the genotoxic
agents as described in the legend of Figure 3.198 Structure 15, 191–199, February 2007 ª2007 Elsevier Ltd AWestern Blots to Assess the Levels of H3-K56 Acetylation
Denaturing protein extracts were prepared by trichloroacetic acid
precipitation and glass bead breakage as previously described (Foiani
et al., 1994). Cellular proteins were then resolved on SDS-15% poly-
acrylamide gels and transferred to nitrocellulose membranes. Mem-
branes were then incubated with a 1/1000 dilution of rabbit anti-H3-
K56-acetyl antibodies (Upstate Biotechnology) or a 1/1000 dilution of
rabbit anti-H3-C-terminal (100–135) antibodies (Abcam, 1791) fol-
lowed by a 1/5000 dilution of horseradish peroxidase-conjugated
anti-rabbit antibodies and Pierce Pico sensitivity chemiluminescent
reagents according to the manufacturer’s directions.
Coimmunoprecipitation of Asf1-Myc with H3/H4
Yeast strains expressing uniquely wild-type Hht2 or the Hht2-RE129E
mutant were transformed with a URA3 vector or plasmids expressing
Asf1-13-myc (Mousson et al., 2005). Four hundred milliliters of cells
was grown at 30C in synthetic complete medium lacking uracil to
an A600 of 0.6. The cells were then centrifuged and resuspended in
4 ml of breaking buffer (40 mM HEPES [pH 7.5], 1 mM DTT, and an
EDTA-free protease inhibitor cocktail [Roche Biochemicals]). Cells
were then broken with an Eaton press and an S100 extract was pre-
pared by centrifugation at 45,000 rpm for 1 hr at 4C in a Beckman
70 Ti rotor. Twenty microliters of EZ-view anti-myc beads (Sigma)
was added to 1 mg of protein extract in an Eppendorf tube and incu-
bated on a rotary shaker overnight at 4C. The anti-myc beads were
then washed four times with extraction buffer containing 0.1% NP-
40 and the beads were transferred to a fresh tube before the last
wash. Proteins bound to the anti-myc beads were solubilized by the
addition of SDS sample buffer and heating at 95C for 5 min. Eluted
proteins were then electrophoresed on discontinuous SDS-10%/
15% polyacrylamide gels and the resolved proteins were transferred
to nitrocellulose membranes. Asf1-myc, histone H3, and histone H4
proteins were visualized by incubating with 1/5000 dilutions of mouse
9E10 anti-myc antibodies, rabbit anti-H3 antibodies (Abcam, 1791),
and rabbit anti-H4-K8/12-acetyl antibodies (Upstate Biotechnology)
followed by incubation with 1/10,000 dilutions of donkey anti-
mouse-680 and anti-rabbit-800 antibodies and scanning with an
Odyssey infrared imaging system (LI-COR Biosciences).
Supplemental Data
Supplemental Data include two figures and one table and can be found
with this article online at http://www.structure.org/cgi/content/full/15/
2/191/DC1/.
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